LONDON, August 17, 2017 /PRNewswire/ --
Infectious Disease Testing, Oncology Testing, Blood Screening, Genetic Testing, Tissue Typing
The molecular diagnostics (MDx) market was worth $6.13bn in 2016 and is estimated to grow at a CAGR of 12.5% from 2017-2021. The fastest growing segment of the molecular diagnostics market over the forecast period 2017-2027 will be the oncology testing segment. The segment was worth $1.08bn in 2016 and represented 17.6% of the molecular diagnostics market.
How this report will benefit you:
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 206-page report you will receive 135 charts - all unavailable elsewhere.
The 206-page report provides clear detailed insight into the molecular diagnostics (MDx) market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
• World IVD market forecasts from 2017-2027
• Molecular diagnostics (MDx) market forecasts from 2017-2027
The Molecular Diagnostics (MDx) Market Forecast 2017-2027
• Revenue and growth forecasts to 2027 for the leading submarkets:
• Infectious Disease Testing
• Oncology Testing
• Blood Screening
• Genetic Testing
• Tissue Typing
• This report provides individual revenue forecasts to 2027 for these regional and national markets:
• Rest of Europe
- South Korea
• This report discusses the leading companies in the molecular diagnostics (MDx) market:
• Roche Diagnostics
• Becton, Dickinson & Company
• Agilent Technologies
A company profile gives you the following information where available:
• Discussion of a company's activities and outlook
• Analysis of assays and instruments currently on the market as well as pipeline products
• Acquisitions and strategic partnerships
• This report discusses the SWOT analysis as well as porter's five forces analysis of the molecular diagnostics (MDx) market
Visiongain's study is intended for anyone requiring commercial analyses for the molecular diagnostics (MDx). You find data, trends and predictions.
Buy our report today The Molecular Diagnostics (MDx) Market Forecast 2017-2027: Infectious Disease Testing, Oncology Testing, Blood Screening, Genetic Testing, Tissue Typing.
To request a report overview of this report please email Sara Peerun at firstname.lastname@example.org or call Tel: +44-(0)-20-7336-6100
Companies Mentioned in the Report:
Abbott Laboratories / Abbott Molecular
Becton, Dickinson & Co. / BD Diagnostics
Bina Technologies, Inc.
Bristo Myers Squibb
EliTechGroup Epoch Biosciences
Exact Sciences Corporation
Focus Diagnostics, Inc.
Genia Technologies, Inc.
GeneWEAVE Biosciences, Inc.
Great Basin Scientific, Inc.
Infectio Diagnstic, Inc.
Intelligent Medical Devices, Inc.
IRIS International, Inc.
Janssen Diagnostics, LLC
Keysight Technologies Inc.
KIESTRA Lab Automation BV
Luminex Molecular Diagnostics, Inc.
Meridian Bioscience, Inc.
Meso Scale Diagnsotics
Myriad Genetic Laboratories, Inc.
Olerup SSP AB
Ortho Clinical Diagnostics
Osmetech Molecular Diagnostics
Quest Diagnostics, Inc.
RAS Lifesciences Pvt. Ltd
Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
Saladax Biomedical Inc.
Santaris Pharma A/S
Seragon Pharmaceuticals, Inc.
Siemens Healthcare Diagnostics
Signature Diagnostics AG
Texas BioGene Inc.
Thermo Fisher Scientific
Ventana Medical Systems, Inc.
To see a report overview please email Sara Peerun on email@example.com
SOURCE Visiongain Ltd